Sign in
MP54-14 SEQUENTIAL INTRAVESICAL GEMCITABINE/DOCETAXEL PROVIDES A DURABLE REMISSION IN RECURRENT HIGH RISK NMIBC FOLLOWING BCG THERAPY
Abstract   Peer reviewed

MP54-14 SEQUENTIAL INTRAVESICAL GEMCITABINE/DOCETAXEL PROVIDES A DURABLE REMISSION IN RECURRENT HIGH RISK NMIBC FOLLOWING BCG THERAPY

Kendrick Yim, Kevin Melnick, Sarah L. Mott, Vani Gupta, Timothy N. Clinton, Filipe L.F. Carvalho, Matthew Mossanen, Graeme S. Steele, Kent Mouw, Michael A. O'Donnell, …
The Journal of urology, Vol.207(Supplement 5)
05/2022
DOI: 10.1097/JU.0000000000002633.14

View Online

Details

Metrics

1 Record Views